Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 2/2017

01-02-2017 | Letter to the Editor

The need for differentiating diabetes-specific mortality from total mortality when comparing metformin with insulin regarding cancer survival

Authors: Min Wei, Yu Liu, Chunhong Wang, Chuanhua Yu, Dejia Li, Wei Zhou, Zhi-Jiang Zhang

Published in: Acta Diabetologica | Issue 2/2017

Login to get access

Excerpt

Fransgaard and colleague examined the association between metformin and overall survival after surgical resection for colorectal cancer (CRC) [1]. The adjusted hazard ratio was 0.85 (95% confidence interval 0.73–0.93, P = 0.03) for the metformin-treated group compared with the insulin-treated group. The effect estimates for other oral antidiabetic medication (hazard ratio 0.91) and diet (hazard ratio 0.84) were not statistically significant, but was comparable to that of metformin. …
Literature
1.
Fransgaard T, Thygesen LC, Gögenur I (2016) Metformin increases overall survival in patients with diabetes undergoing surgery for colorectal cancer. Ann Surg Oncol 23:1569–1575CrossRefPubMed
2.
Zhang ZJ, Li S (2014) The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis. Diabetes Obes Metab 16(8):707–710CrossRefPubMed
3.
Zhang ZJ, Zheng ZJ, Kan H et al (2011) Reduced risk of colorectal cancer with metformin therapy in patients with type 2 diabetes: a meta-analysis. Diabetes Care 34(10):2323–2328CrossRefPubMedPubMedCentral
4.
Zhang ZJ, Bi Y, Li S et al (2014) Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis. Am J Epidemiol 180(1):11–14CrossRefPubMed
5.
Gallo M, Gentile L, Arvat E, Bertetto O, Clemente G (2016) Diabetology and oncology meet in a network model: union is strength. Acta Diabetol 53(4):515–524CrossRefPubMed
Metadata
Title
The need for differentiating diabetes-specific mortality from total mortality when comparing metformin with insulin regarding cancer survival
Authors
Min Wei
Yu Liu
Chunhong Wang
Chuanhua Yu
Dejia Li
Wei Zhou
Zhi-Jiang Zhang
Publication date
01-02-2017
Publisher
Springer Milan
Published in
Acta Diabetologica / Issue 2/2017
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-016-0933-2

Other articles of this Issue 2/2017

Acta Diabetologica 2/2017 Go to the issue

Case Report

Reactive hypoglycaemia with seizure following intraduodenal glucose infusion in a patient with type 2 diabetes

Original Article

Curvilinear associations of sleep patterns during weekdays and weekends with glycemic control in type 2 diabetes: the Hong Kong Diabetes Registry

Original Article

Mediterranean meal versus Western meal effects on postprandial ox-LDL, oxidative and inflammatory gene expression in healthy subjects: a randomized controlled trial for nutrigenomic approach in cardiometabolic risk

Original Article

Are all people with diabetes and cardiovascular risk factors or microvascular complications at very high risk? Findings from the Risk and Prevention Study

Original Article

Proteomic analysis reveals downregulation of housekeeping proteins in the diabetic vascular proteome

Original Article

Retrograde cholesterol transport in the human Caco-2/TC7 cell line: a model to study trans-intestinal cholesterol excretion in atherogenic and diabetic dyslipidemia
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits